Skip to content

A Retrospective Analysis of the Adherence to Clinical Practice Guidelines Using the MedicBK Digital Platform in Patients With Hypertension and Atrial Fibrillation

A Retrospective Analysis of the Adherence to Clinical Practice Guidelines Using the MedicBK Digital Platform in Patients With Hypertension and Atrial Fibrillation (the INTELLECT Trial)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04564118
Acronym
INTELLECT
Enrollment
191
Registered
2020-09-25
Start date
2020-09-01
Completion date
2021-01-11
Last updated
2021-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Hypertension, Atrial Fibrillation

Keywords

atrial fibrillation, arterial hypertension, digital medicine, Clinical Decision Support System

Brief summary

The Clinical Decision Support Systems (CDSS) based on real clinical data and its own algorithms can help to make the right choice. This trial is designed to assess the difference between retrospective electronic medical cards (EMC) therapy prescriptions and MedicBK prescriptions based on key patient characteristics.

Detailed description

There is a lot of data from registries about poor adherence to guidelines. It is connected with a problem that patients usually have a lot of comorbidities and physicians need to know сonsequently the huge number of medications and combinations. It is very difficult to decide quickly according to available data from libraries like PubMed. The Clinical Decision Support Systems (CDSS) based on real clinical data and its own Artificial Intelligence algorithms can help to make the right choice. This trial is designed to assess the difference between retrospective electronic medical cards (EMC) therapy prescriptions and MedicBK prescriptions based on key patient characteristics. Two groups of experts (cardiologists with clinical practice for more than 5 years) will be participating in the trial. Using main characteristics from EMC the first group of experts will put this data into MedicBK platform and assess retrospective treatment. The next blinded group of experts will perform prescriptions using MedicBK algorithms based on current guidelines and data from available clinical trials. The main hypothesis is the use Clinical Decision Support Systems (CDSS) better than current clinical practice. This option can help to make the right choice of medical combination based on main patient's clinical characteristics

Interventions

analysis of treatment assigned by physicians within routine clinical practice

Sponsors

Medicbook LLC
CollaboratorUNKNOWN
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 years old 2. Patients diagnosed with nonvalvular atrial fibrillation and essential hypertension having indications for therapy according to European guidelines.

Exclusion criteria

1. Valvular cause of atrial fibrillation 2. GFR less than 30 ml / min 3. Active liver disease 4. Acute coronary syndrome 5. The presence of thyroid diseases as a cause of atrial fibrillation 6. Secondary arterial hypertension

Design outcomes

Primary

MeasureTime frameDescription
Assessment of AF/AH treatment guidelines compliance1 MONTHNumber of electronic medical records not compliant to the AF/AH clinical practice guidelines

Secondary

MeasureTime frameDescription
Assessment of MedicBK programme1 MONTHNumber of prescriptions from electronic medical records appropriate or inappropriate according to the AF/hypertension clinical practice guidelines in comparison with the treatment's choice of CDSS platform

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026